|
2015
|
Invention
|
Treatment of pemphigus. The present invention concerns treatment of pemphigus with an antibody wh... |
|
|
Invention
|
Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody.
New ... |
|
2014
|
G/S
|
Reminder services of dates and events and providing medical information |
|
|
Invention
|
Fc receptor (fcrn) binding peptides and uses thereof. The invention provided herein includes isol... |
|
|
Invention
|
Treatment of multiple sclerosis.
The present invention concerns treatment of autoimmune diseases... |
|
2013
|
Invention
|
Deuterium substituted fumarate derivatives.
Provided is a compound of formula (I):
Provided is... |
|
|
Invention
|
Sp35 antibodies and uses thereof.
Endogenous Sp35 is a negative regulator for neuronal survival,... |
|
|
Invention
|
Methods of using fviii polypeptide. The present invention provides methods of reducing or decreas... |
|
|
Invention
|
Methods of using a fixed dose of a clotting factor. The present invention provides methods of adm... |
|
|
Invention
|
Combination therapies and uses for treatment of demyelinating disorders.
Methods and composition... |
|
|
Invention
|
Combination therapies and uses for treatment of demyelinating disorders. Methods and compositions... |
|
|
Invention
|
Methods of using fix polypeptides. The present invention provides methods of administering long-a... |
|
|
Invention
|
Genetically engineered plant cells and plants exhibiting resistance to glutamine synthetase inhib... |
|
|
Invention
|
Treatment of pemphigus.
The present invention concerns treatment of pemphigus with an antibody w... |
|
|
Invention
|
Novel compounds for modulation of ror-gamma activity. The present invention relates to aryl sulfo... |
|
|
Invention
|
Disease progression parameters and uses thereof for evaluating multiple sclerosis. Methods, syste... |
|
|
Invention
|
Methods and compositions for inactivating enveloped viruses. Aspects of the invention provide the... |
|
|
Invention
|
Compounds that are s1p modulating agents and/or atx modulating agents. Compounds of formula (I) c... |
|
|
Invention
|
Methods for pancreatic tissue regeneration.
Disclosed are methods of expanding populations of pa... |
|
|
Invention
|
Atx modulating agents. Disclosed are bicyclic aryl compounds of formula (I), that can modulate th... |
|
|
Invention
|
Atx modulating agents. Compounds of formula (I) can modulate the activity of autotaxin (ATX). |
|
|
Invention
|
Blood factor monitoring assay and uses thereof. The present disclosure provides methods and compo... |
|
|
Invention
|
Factor viii complex with xten and von willebrand factor protein, and uses thereof. The present in... |
|
|
Invention
|
Cell line expressing single chain factor viii polypeptides and uses thereof. The present inventio... |
|
|
Invention
|
Device container. Device containers, such as therapeutic kit containers, are disclosed. In one em... |
|
|
Invention
|
Biaryl-containing compounds as inverse agonists of ror-gamma receptors. The present invention rel... |
|
|
Invention
|
Use of chimeric anti-cd20 antibody as in vitro or in vivo purging agent in patients receiving bmt... |
|
|
Invention
|
Procoagulant compounds. The present disclosure provides protease-activatable procoagulant compoun... |
|
|
Invention
|
Inhibitors of bruton's tyrosine kinase. The present invention provides a compound, solid forms, a... |
|
|
Invention
|
Pyrimidinyl tyrosine kinase inhibitors. The present invention provides compounds and compositions... |
|
|
Invention
|
Chimeric clotting factors. The invention provides chimeric clotting factors comprising an activat... |
|
|
Invention
|
Trapping reagents for reactive metabolites screening. The present invention provides compounds of... |
|
|
Invention
|
Lingo-2 antagonists for treatment of conditions involving motor neurons. The invention provides m... |
|
|
Invention
|
Cognitive composite parameters and uses thereof for evaluating multiple sclerosis. Methods, syste... |
|
|
Invention
|
Methods of detecting glycosaminoglycans. In one aspect, the disclosure provides methods of distin... |
|
|
Invention
|
Delivery device and components thereof. Delivery devices and components thereof are disclosed. In... |
|
|
Invention
|
Biomarkers for use in integrin therapy applications. The present invention relates to biomarkers ... |
|
|
Invention
|
Jcv neutralizing antibodies. In one aspect, the disclosure provides neutralizing antibodies again... |
|
|
Invention
|
Neuroprotection in demyelinating diseases.
Methods of treating neurological disorders characteri... |
|
|
Invention
|
Cripto binding molecules.
The invention pertains to humanized forms of an anti-CRIPTO antibody a... |
|
|
Invention
|
High-throughput method for sialic acid quantitation. The present invention relates to a method fo... |
|
|
Invention
|
Recombinant factor viii proteins. Provided are recombinant Factor VIII proteins, e.g., human Fact... |
|
|
Invention
|
Pharmaceutical compositions containing dimethyl fumarate.
Provided herein are compositions conta... |
|
|
Invention
|
Pharmaceutical compositions containing dimethyl fumarate. Provided herein are compositions contai... |
|
|
Invention
|
Methods of reducing immunogenicity against factor viii in individuals undergoing factor viii ther... |
|
2012
|
Invention
|
Factor viii compositions and methods of making and using same. The present invention relates to c... |
|
2011
|
G/S
|
Medical diagnostic reagents; medical diagnostic reagents and assays for testing of body fluids. |
